$INGN
Inogen Inc

2022 Q1 Form 10-Q Financial Statement

#000156459022018264 Filed on May 05, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $80.39M $86.93M
YoY Change -7.53% -1.76%
Cost Of Revenue $45.38M $47.06M
YoY Change -3.57% -6.11%
Gross Profit $35.01M $39.87M
YoY Change -12.21% 3.93%
Gross Profit Margin 43.55% 45.87%
Selling, General & Admin $43.23M $38.00M
YoY Change 13.76% 2.98%
% of Gross Profit 123.49% 95.3%
Research & Development $5.364M $4.000M
YoY Change 34.1% 11.11%
% of Gross Profit 15.32% 10.03%
Depreciation & Amortization $5.760M $5.098M
YoY Change 12.99% 14.25%
% of Gross Profit 16.45% 12.79%
Operating Expenses $48.59M $42.01M
YoY Change 15.68% 3.46%
Operating Profit -$13.59M -$2.132M
YoY Change 537.24% -4.57%
Interest Expense $29.00K $100.0K
YoY Change -71.0% -83.33%
% of Operating Profit
Other Income/Expense, Net -$404.0K -$253.0K
YoY Change 59.68% 321.67%
Pretax Income -$13.99M -$2.385M
YoY Change 486.58% 41.38%
Income Tax $224.0K -$1.653M
% Of Pretax Income
Net Earnings -$14.21M -$732.0K
YoY Change 1841.8% -53.93%
Net Earnings / Revenue -17.68% -0.84%
Basic Earnings Per Share -$0.62 -$0.03
Diluted Earnings Per Share -$0.62 -$0.03
COMMON SHARES
Basic Shares Outstanding 22.75M 22.18M
Diluted Shares Outstanding 22.75M 22.18M

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $223.4M $233.2M
YoY Change -4.19% 11.88%
Cash & Equivalents $213.4M $220.0M
Short-Term Investments $9.989M $13.14M
Other Short-Term Assets $25.24M $9.700M
YoY Change 160.19% -30.22%
Inventory $34.08M $26.39M
Prepaid Expenses
Receivables $33.98M $38.43M
Other Receivables $1.435M $2.000M
Total Short-Term Assets $318.1M $309.7M
YoY Change 2.72% 2.21%
LONG-TERM ASSETS
Property, Plant & Equipment $39.33M $31.05M
YoY Change 26.65% 57.89%
Goodwill $32.93M $33.06M
YoY Change -0.37% 0.43%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.151M $18.60M
YoY Change -88.44% 238.06%
Total Long-Term Assets $156.5M $166.8M
YoY Change -6.18% 6.83%
TOTAL ASSETS
Total Short-Term Assets $318.1M $309.7M
Total Long-Term Assets $156.5M $166.8M
Total Assets $474.6M $476.5M
YoY Change -0.4% 3.79%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $18.11M $14.61M
YoY Change 23.98% -22.01%
Accrued Expenses $16.17M $16.70M
YoY Change -3.2% 23.7%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $59.82M $55.50M
YoY Change 7.79% -0.62%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $56.51M $64.70M
YoY Change -12.66% 15.74%
Total Long-Term Liabilities $56.51M $64.70M
YoY Change -12.66% 15.74%
TOTAL LIABILITIES
Total Short-Term Liabilities $59.82M $55.50M
Total Long-Term Liabilities $56.51M $64.70M
Total Liabilities $116.3M $120.2M
YoY Change -3.22% 7.49%
SHAREHOLDERS EQUITY
Retained Earnings $55.06M
YoY Change
Common Stock $302.0M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $358.3M $356.3M
YoY Change
Total Liabilities & Shareholders Equity $474.6M $476.5M
YoY Change -0.4% 3.79%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income -$14.21M -$732.0K
YoY Change 1841.8% -53.93%
Depreciation, Depletion And Amortization $5.760M $5.098M
YoY Change 12.99% 14.25%
Cash From Operating Activities -$18.10M $2.860M
YoY Change -732.8% 429.63%
INVESTING ACTIVITIES
Capital Expenditures $1.366M $1.516M
YoY Change -9.89% 2.5%
Acquisitions
YoY Change
Other Investing Activities $91.00K $6.170M
YoY Change -98.53% -44.46%
Cash From Investing Activities -$4.052M $986.0K
YoY Change -510.95% -88.92%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -108.0K 4.427M
YoY Change -102.44% 354.05%
NET CHANGE
Cash From Operating Activities -18.10M 2.860M
Cash From Investing Activities -4.052M 986.0K
Cash From Financing Activities -108.0K 4.427M
Net Change In Cash -22.13M 8.052M
YoY Change -374.78% -22.01%
FREE CASH FLOW
Cash From Operating Activities -$18.10M $2.860M
Capital Expenditures $1.366M $1.516M
Free Cash Flow -$19.46M $1.344M
YoY Change -1548.21% -243.13%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y4M9D
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y14D
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P1Y14D
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P1Y14D
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2151000
CY2022Q1 us-gaap Assets
Assets
474616000
CY2022Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
32375000
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8839000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22731586
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
23000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
23000
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3401000
CY2022Q1 ingn Contract With Customer Liability And Lease Deferred Revenue Current
ContractWithCustomerLiabilityAndLeaseDeferredRevenueCurrent
8689000
CY2021Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
75000
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
59823000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
61512000
CY2022Q1 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
6574000
CY2021Q4 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
7246000
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
22409000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
23281000
CY2022Q1 ingn Earnout Liability Noncurrent
EarnoutLiabilityNoncurrent
16016000
CY2021Q4 ingn Earnout Liability Noncurrent
EarnoutLiabilityNoncurrent
15386000
CY2022Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
11509000
CY2022Q1 us-gaap Liabilities
Liabilities
116331000
CY2021Q4 us-gaap Liabilities
Liabilities
119286000
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22836472
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22836472
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22731586
CY2022Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
302020000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
299463000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
55058000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
69272000
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1184000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1469000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
358285000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
370227000
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
474616000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
489513000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
77081000
CY2022Q1 us-gaap Revenues
Revenues
80385000
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
39500000
CY2021Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
42635000
CY2022Q1 us-gaap Cost Of Goods And Services Sold Depreciation
CostOfGoodsAndServicesSoldDepreciation
2638000
CY2021Q1 us-gaap Cost Of Goods And Services Sold Depreciation
CostOfGoodsAndServicesSoldDepreciation
1888000
CY2022Q1 ingn Cost Of Rental
CostOfRental
5879000
CY2021Q1 ingn Cost Of Rental
CostOfRental
4424000
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
45379000
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-74000
CY2021Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
903000
CY2021Q1 us-gaap Cost Of Revenue
CostOfRevenue
47059000
CY2022Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-8000
CY2021Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
4000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-285000
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
450000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14499000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-14214000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-732000
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-203000
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-457000
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
-528000
CY2021Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
1144000
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-454000
CY2021Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
241000
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
42005000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2132000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-433000
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-404000
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-253000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13990000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2385000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
224000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1653000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-282000
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.62
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.62
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22754421
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22181394
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22754421
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22181394
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
349623000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2516000
CY2021Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
927000
CY2021Q1 ingn Stock Issued During Period Value Vesting Of Restricted Stock Units
StockIssuedDuringPeriodValueVestingOfRestrictedStockUnits
275000
CY2021Q1 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
91000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3866000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-732000
CY2022Q1 us-gaap Inventory Write Down
InventoryWriteDown
934000
CY2021Q1 us-gaap Inventory Write Down
InventoryWriteDown
518000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2665000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2516000
CY2021Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1527000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
356284000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
370227000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2665000
CY2022Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
915000
CY2022Q1 ingn Stock Issued During Period Value Vesting Of Restricted Stock Units
StockIssuedDuringPeriodValueVestingOfRestrictedStockUnits
958000
CY2022Q1 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
94000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
29000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-14214000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-285000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
358285000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-14214000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5760000
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5098000
CY2022Q1 ingn Gain Loss On Write Off Of Rental Units And Other Fixed Assets
GainLossOnWriteOffOfRentalUnitsAndOtherFixedAssets
-706000
CY2021Q1 ingn Gain Loss On Write Off Of Rental Units And Other Fixed Assets
GainLossOnWriteOffOfRentalUnitsAndOtherFixedAssets
-158000
CY2022Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
52000
CY2021Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
24000
CY2022Q1 ingn Provision For Sales Returns And Doubtful Accounts
ProvisionForSalesReturnsAndDoubtfulAccounts
2953000
CY2021Q1 ingn Provision For Sales Returns And Doubtful Accounts
ProvisionForSalesReturnsAndDoubtfulAccounts
2471000
CY2021Q1 ingn Health Care Organization Patient Service Revenue Adjustments
HealthCareOrganizationPatientServiceRevenueAdjustments
1041000
CY2022Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
630000
CY2021Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
265000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
12802000
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
12418000
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2515000
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2686000
CY2022Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
92000
CY2021Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-64000
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-764000
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-8171000
CY2022Q1 ingn Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-832000
CY2021Q1 ingn Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
8696000
CY2022Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-66000
CY2021Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-41000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
6539000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3526000
CY2022Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-8465000
CY2021Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
2105000
CY2022Q1 ingn Increase Decrease In Warranty Reserve
IncreaseDecreaseInWarrantyReserve
-633000
CY2021Q1 ingn Increase Decrease In Warranty Reserve
IncreaseDecreaseInWarrantyReserve
520000
CY2022Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-231000
CY2021Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
518000
CY2022Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-79000
CY2021Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
80000
CY2022Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-864000
CY2021Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
8903000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-18098000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2860000
CY2021Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
6125000
CY2021Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
26000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1366000
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1516000
CY2022Q1 ingn Payments To Produce And Purchase Rental Equipment
PaymentsToProduceAndPurchaseRentalEquipment
2777000
CY2021Q1 ingn Payments To Produce And Purchase Rental Equipment
PaymentsToProduceAndPurchaseRentalEquipment
3643000
CY2022Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
91000
CY2021Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
46000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4052000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
986000
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
29000
CY2021Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3866000
CY2022Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
915000
CY2021Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
927000
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1052000
CY2021Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
366000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-108000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4427000
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
133000
CY2021Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-221000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-22125000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8052000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
235524000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
211962000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
213399000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
220014000
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
372000
CY2021Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
17000
CY2022Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
91000
CY2021Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
77000
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Management bases these estimates and assumptions upon historical experience, existing and known circumstances, authoritative accounting pronouncements and other factors that management believes to be reasonable. Significant areas requiring the use of management estimates relate to revenue recognition, warranty reserves and expense, determining the stand-alone selling price (SSP) and service period of performance obligations, rental asset valuations and write-downs, accounts receivable allowances for bad debts, returns and adjustments, impairment of long-lived assets, stock-based compensation expense, income taxes, fair value of acquired intangible assets and goodwill and fair value of earnout liabilities. Actual results could differ from these estimates. </p>
CY2022Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2022Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-285000
CY2022Q1 ingn Preacquisition Loss Recoveries
PreacquisitionLossRecoveries
630000
CY2021 ingn Preacquisition Loss Recoveries
PreacquisitionLossRecoveries
630000
CY2022Q1 us-gaap Cash
Cash
36677000
CY2021Q4 us-gaap Cash
Cash
48817000
CY2022Q1 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
176722000
CY2021Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
186707000
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
213399000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
235524000
CY2022Q1 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
9989000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
9989000
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
33983000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
24452000
CY2022Q1 ingn Allowances For Sales Returns
AllowancesForSalesReturns
969000
CY2021Q4 ingn Allowances For Sales Returns
AllowancesForSalesReturns
810000
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1022000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
862000
CY2022Q1 ingn Percentage Of Non Us Revenue Invoiced In Euros
PercentageOfNonUSRevenueInvoicedInEuros
0.732
CY2022Q1 us-gaap Revenues
Revenues
80385000
CY2021Q1 us-gaap Revenues
Revenues
86932000
CY2022Q1 ingn Transfer Of Inventory To Rental Equipment
TransferOfInventoryToRentalEquipment
533000
CY2021Q1 ingn Transfer Of Inventory To Rental Equipment
TransferOfInventoryToRentalEquipment
607000
CY2021Q4 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
21909000
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
12116000
CY2021Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
2152000
CY2022Q1 us-gaap Inventory Net
InventoryNet
34078000
CY2021Q4 us-gaap Inventory Net
InventoryNet
31873000
CY2022Q1 us-gaap Property Plant And Equipment Salvage Value
PropertyPlantAndEquipmentSalvageValue
0
CY2021Q1 us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
935000
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3613000
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2834000
CY2021Q4 ingn Rental Equipment Allowance
RentalEquipmentAllowance
1290000
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
90685000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
90595000
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
51356000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
51669000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
39329000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
38926000
CY2021Q4 us-gaap Goodwill
Goodwill
32979000
CY2022Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
45000
CY2022Q1 us-gaap Goodwill
Goodwill
32934000
CY2022Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2021 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2022Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
84085000
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
26085000
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
58000000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
24417000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
60147000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
6365000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
7854000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
7821000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
7790000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
7774000
CY2022Q1 ingn Finite Lived Intangible Assets Amortization Expense After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
20396000
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
58000000
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
18109000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
10258000
CY2022Q1 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
10340000
CY2021Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
12488000
CY2022Q1 ingn Accrued Purchasing Card Liability
AccruedPurchasingCardLiability
2508000
CY2021Q4 ingn Accrued Purchasing Card Liability
AccruedPurchasingCardLiability
1488000
CY2022Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
492000
CY2021Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
486000
CY2022Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
926000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
969000
CY2022Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
32375000
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
25689000
CY2022Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
1292000
CY2021Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
8274000
CY2022Q1 ingn Accrued Wages And Other Payroll Related Items Current
AccruedWagesAndOtherPayrollRelatedItemsCurrent
4221000
CY2021Q4 ingn Accrued Wages And Other Payroll Related Items Current
AccruedWagesAndOtherPayrollRelatedItemsCurrent
5469000
CY2022Q1 us-gaap Accrued Vacation Current
AccruedVacationCurrent
3012000
CY2021Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
2894000
CY2022Q1 ingn Accrued Employee Stock Purchase Plan Deductions
AccruedEmployeeStockPurchasePlanDeductions
314000
CY2021Q4 ingn Accrued Employee Stock Purchase Plan Deductions
AccruedEmployeeStockPurchasePlanDeductions
670000
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8839000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
17307000
CY2022Q1 us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
options to extend the leases for up to 5 years.
CY2022Q1 ingn Rent Expense Including Short Term Lease Cost
RentExpenseIncludingShortTermLeaseCost
971000
CY2021Q1 ingn Rent Expense Including Short Term Lease Cost
RentExpenseIncludingShortTermLeaseCost
987000
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
1008000
CY2021Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
554000
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
975000
CY2021Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
763000
CY2021Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
9340000
CY2022Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y8M12D
CY2021Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.029
CY2021Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.032
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths
3945000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Two
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo
3965000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Three
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree
3362000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Four
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour
2702000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Five
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive
2716000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due After Rolling Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive
11416000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
28106000
CY2022Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2296000
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
25810000
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3401000
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
22409000
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
25810000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-14214000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-732000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22754421
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22181394
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22754421
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22181394
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.62
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.62
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22754421
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22181394
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
88193
CY2021Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
341716
CY2022Q1 ingn Weighted Average Number Of Diluted Shares Outstanding Based On Net Loss
WeightedAverageNumberOfDilutedSharesOutstandingBasedOnNetLoss
22842614
CY2021Q1 ingn Weighted Average Number Of Diluted Shares Outstanding Based On Net Loss
WeightedAverageNumberOfDilutedSharesOutstandingBasedOnNetLoss
22523110
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
958132
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
373285
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
459441
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
42.18
CY2021 ingn Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Intrinsic Value Per Share
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValuePerShare
4.31
CY2022Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
3499
CY2022Q1 ingn Share Based Compensation Arrangement By Share Based Payment Award Per Share Price Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardPerSharePriceExercised
8.37
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
8.37
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
7500
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
42.31
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
448442
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
42.44
CY2022Q1 ingn Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Intrinsic Value Per Share
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValuePerShare
3.97
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
448442
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
42.44
CY2022Q1 ingn Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Vested And Exercisable Per Share Average Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsVestedAndExercisablePerShareAverageIntrinsicValue
3.97
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
448442
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
42.44
CY2022Q1 ingn Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Vested And Expected To Vest Per Share Average Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsVestedAndExpectedToVestPerShareAverageIntrinsicValue
3.97
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
84000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
6504000
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2665000
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2516000
CY2022Q1 us-gaap Purchase Obligation Due In Next Twelve Months
PurchaseObligationDueInNextTwelveMonths
122900000
CY2021Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
13726000
CY2020Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
14394000
CY2022Q1 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
1330000
CY2021 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
9168000
CY2022Q1 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
873000
CY2021 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
-597000
CY2022Q1 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
2836000
CY2021 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
9239000
CY2022Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
13093000
CY2021Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
13726000
CY2022Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1595000
CY2022Q1 ingn Contract With Customer Performance Obligations To Be Satisfied In Future Periods
ContractWithCustomerPerformanceObligationsToBeSatisfiedInFuturePeriods
1342000
CY2022Q1 ingn Number Of Contract Designated Hedges
NumberOfContractDesignatedHedges
8
CY2022Q1 ingn Number Of Contract Non Designated Hedges
NumberOfContractNonDesignatedHedges
1
CY2021Q1 ingn Number Of Contract Designated Hedges
NumberOfContractDesignatedHedges
22
CY2021Q1 ingn Number Of Contract Non Designated Hedges
NumberOfContractNonDesignatedHedges
2

Files In Submission

Name View Source Status
0001564590-22-018264-index-headers.html Edgar Link pending
0001564590-22-018264-index.html Edgar Link pending
0001564590-22-018264.txt Edgar Link pending
0001564590-22-018264-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
ingn-10q_20220331.htm Edgar Link pending
ingn-10q_20220331_htm.xml Edgar Link completed
ingn-20220331.xsd Edgar Link pending
ingn-20220331_cal.xml Edgar Link unprocessable
ingn-20220331_def.xml Edgar Link unprocessable
ingn-20220331_lab.xml Edgar Link unprocessable
ingn-20220331_pre.xml Edgar Link unprocessable
ingn-ex311_10.htm Edgar Link pending
ingn-ex312_12.htm Edgar Link pending
ingn-ex321_6.htm Edgar Link pending
ingn-ex322_11.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending